Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Spectranetics Corp. (The) SPNC NASDAQ

NASDAQ • Healthcare • Medical Equipment & Supplies • USD

SharesGrow Score
29/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Spectranetics Corp. (The) (SPNC) is a Medical Equipment & Supplies company in the Healthcare sector, currently trading at $38.45. It has a SharesGrow Score of 27/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $271M, +19.7%/yr average growth. Net income is $58M (loss), growing at -3665.8%/yr. Net profit margin is -21.5% (negative). Gross margin is 74.8% (+0.8 pp trend).

Balance sheet: total debt is $334M against $74M equity (Debt-to-Equity (D/E) ratio 4.5, leveraged). Current ratio is 2.02 (strong liquidity). Debt-to-assets is 77.7%. Total assets: $430M.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 48/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 54/100 (Partial), Future ?/100 (Fail), Income 10/100 (Fail).

SPNC SharesGrow Score Overview

36/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 48/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 33/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 54/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SPNC

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
48/100
SPNC: +19.7%/yr revenue is, -3665.8%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
33/100
Balance sheet SPNC: Debt-to-Equity (D/E) ratio 4.5 (leveraged), Current ratio is 2.02 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
54/100
SPNC: Gross margin is 74.8% (+0.8 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 54/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
SPNC: Net profit margin is -21.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range38.55-19.8
Volume1.73M
Avg Volume (30D)630.79K
Beta (1Y)1.65
Share Statistics
EPS (TTM)-1.35
Shares Outstanding$42.94M
IPO Date1992-01-21
Financial Highlights & Ratios
Revenue (TTM)$270.82M
Gross Profit$202.5M
EBITDA$-15.41M
Net Income$-58.12M
Operating Income$-43.64M
Total Cash$57.24M
Total Debt$334.18M
Net Debt$276.95M
Total Assets$430.08M
Price / Earnings (P/E)-28.5
Analyst Forecast
Company Info
ExchangeNASDAQ
CurrencyUSD

Price Chart

Track all markets on TradingView
SPNC
Spectranetics Corp. (The)  ·  NASDAQ
Healthcare • Medical Equipment & Supplies

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message